| Literature DB >> 33997042 |
Jun Ma1, Zhengyu Lu1, Xin Zhou1, Jia Yin1, Enjie Xu1, Heng Jiang1, Xiao Ma1, Yichen Meng1, Zhilin Li2, Rui Gao1, Tao Lin1, Xuhui Zhou1.
Abstract
OBJECTIVE: (1) To propose a novel technique named thoracic extensive laminoplasty (TELP) in curing severe thoracic ligamentum flavum ossification (STOLF) and (2) to compare outcomes between TELP and laminectomy in curing STOLF.Entities:
Mesh:
Year: 2021 PMID: 33997042 PMCID: PMC8081600 DOI: 10.1155/2021/8410317
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Illustration of residual spinal canal area (RSCA-1) and residual spinal cord area (RSCA-2). (a) The area of the normal spinal canal. (b) The area of the narrow spinal canal. RSCA-1 or RSCA-2: S2/S1; RSCA-1 was evaluated by CT; and RSCA-2 was evaluated by MRI.
Figure 2Illustration of the procedures of thoracic extensive laminoplasty (TELP) in a coronal view. (a) The thoracic spine with ossified ligamentum flavum (OLF in brown color). (b) Excision of the spinous process and portion of the lamina (not shown in the picture). (c) Bilateral grooves were made by grinding with a drill, and the lamina was isolated bilaterally. (d, e) Lifting the lamina (OLF in brown color) by towel forceps. (f) Fixation by arch plates and fusion with corticocancellous bone (not shown in the picture). (g) Intraoperative view of the TELP.
Figure 3Illustration of the procedures of thoracic extensive laminoplasty (TELP) in a cross-section view. (a) The level of vertebra with TOLF. (b) Excision of the spinous process and portion of the lamina (not shown in the picture). (c) Bilateral grooves were made by grinding with a drill, and the lamina was isolated bilaterally. (d) Lifting the lamina by towel forceps. (e) Fixation by arch plates and fusion with corticocancellous bone (not shown in the picture).
Figure 4A 45-years old patient with STOLF from T3 to T5 levels who received TELP. (a) Preoperative CT. (b) Preoperative MRI. (c, d) Postoperative standing anteroposterior X-ray at final follow-up. (e) Postoperative MRI at final follow-up. (f) Postoperative CT at final follow-up. (g) Postoperative three-dimensional CT reconstruction at final follow-up.
Figure 5A 49-year-old patient with STOLF from T9 to T11 levels who received laminectomy. (a, b) Preoperative standing anteroposterior X-ray. (c) Preoperative CT. (d) Preoperative MRI. (e, f) Postoperative standing anteroposterior X-ray at final follow-up. (g, h) Postoperative MRI at final follow-up.
Demographic characteristics (mean ± SD or n).
| Item | G1 | G2 |
|
|---|---|---|---|
| Sex, | Male: 35 | Male: 39 | 0.686 |
| Female: 24 | Female: 23 | ||
| Age, years old | 52.2 ± 4.7 | 51.8 ± 7.3 | 0.722 |
| BMI, kg/m2 | 24.1 ± 2.6 | 23.7 ± 3.2 | 0.453 |
| Symptom, | |||
| LB numbness | 42 (71.2) | 46 (74.2) | 0.710 |
| LB spastic paraparesis | 28 (47.5) | 33 (53.2) | 0.526 |
| LB sensory deficits | 49 (83.1) | 51 (82.3) | 0.908 |
| Gait instability | 26 (44.1) | 29 (46.8) | 0.765 |
| Urinary sphincter dysfunction | 18 (30.5) | 22 (35.5) | 0.561 |
| Blood loss, ml | 273.8 ± 31.7 | 281.4 ± 35.8 | 0.220 |
| Operating room time, hours | 3.5 ± 1.8 | 3.8 ± 1.6 | 0.334 |
| Follow-up time, months | 19.4 ± 2.1 | 18.9 ± 2.8 | 0.271 |
| Dural laceration, | 0 | 17 | —— |
| Cerebrospinal fluid leakage, | 0 | 17 | —— |
BMI: body mass index; LB: lower limbs.
Image evaluation (mean ± SD or n).
| Item | G1 | G2 |
|
|---|---|---|---|
| Single level, | 10 | 15 | 0.325 |
| ≥2 levels, | 49 | 47 | |
| DO or DA, | 50 | 52 | 0.895 |
| RSCA-1 | |||
| Preoperation, % | 37.9 ± 2.5 | 38.1 ± 3.2 | 0.703 |
| Postoperation, % | 78.2 ± 5.3 | 78.1 ± 4.8 | 0.913 |
| | <0.0001 | <0.0001 | —— |
| Improvement, % | 40.3 ± 3.9 | 40.0 ± 4.1 | 0.681 |
| RSCA-2 | |||
| Preoperation, % | 37.2 ± 2.8 | 37.6 ± 2.6 | 0.417 |
| Postoperation, % | 79.4 ± 4.4 | 78.8 ± 3.9 | 0.428 |
| | <0.0001 | <0.0001 | —— |
| Improvement, % | 42.2 ± 3.3 | 41.2 ± 2.9 | 0.079 |
Postoperation: postoperation at final follow-up. DO or DA: dural ossification or dural adhesion.
Neurological evaluation based on mJOA (mean ± SD or n).
| Item | G1 | G2 |
|
|---|---|---|---|
| Preoperation | 4.2 ± 1.4 | 4.3 ± 1.7 | 0.725 |
| Postoperation | 8.1 ± 1.9 | 7.9 ± 1.6 | 0.532 |
|
| <0.0001 | <0.0001 | —— |
| ≥50% | 31 | 18 | 0.008 |
| <50% | 28 | 44 | |
| OR (95% CI) | 2.706 (1.279~5.727) | —— | |
Recovery rate. Postoperation: postoperation at final follow-up.
HRQOL of the patients based on SF-36 (mean ± SD or n).
| Item | PF | BP | GH | RHT | ||||
|---|---|---|---|---|---|---|---|---|
| G1 | G2 | G1 | G2 | G1 | G2 | G1 | G2 | |
| Pre | 31.2 ± 11.4 | 31.7 ± 12.1 | 52.9 ± 11.7 | 53.1 ± 10.8 | 37.4 ± 13.9 | 37.2 ± 10.7 | 28.9 ± 8.7 | 28.2 ± 9.5 |
| Post | 71.6 ± 13.9 | 64.8 ± 11.7 | 80.6 ± 9.4 | 74.3 ± 7.1 | 73.4 ± 16.5 | 66.2 ± 12.2 | 70.7 ± 11.1 | 66.4 ± 10.9 |
| P1 (G1/G2) | Pre: 0.816 | Pre: 0.922 | Pre: 0.268 | Pre: 0.674 | ||||
| Post: 0.004 | Post: <0.0001 | Post: 0.007 | Post: 0.034 | |||||
| P2 (pre/post) | G1: <0.0001 | G1: <0.0001 | G1: <0.0001 | G1: <0.0001 | ||||
| G2: <0.0001 | G2: <0.0001 | G2: <0.0001 | G2: <0.0001 | |||||
| T/F | T/F | T/F | T/F | T/F | T/F | T/F | T/F | |
| ≥50% | 23/11 | 10/15 | 28/11 | 13/9 | 26/12 | 12/13 | 22/12 | 11/14 |
| <50% | 8/17 | 20/17 | 3/17 | 17/23 | 5/16 | 18/19 | 9/16 | 19/18 |
|
| 0.007 | 0.277 | <0.0001 | 0.211 | 0.001 | 0.960 | 0.029 | 0.570 |
| OR | 4.443 | — | 14.424 | — | 6.933 | — | 3.259 | — |
| (95% CI) | (1.471~13.423) | — | (3.516~59.181) | — | (2.057~23.368) | — | (1.109~9.576) | — |
PF: physical functioning; BP: bodily pain; GH: general health; RHT: reported health transition; Pre: preoperation; Post: postoperation at final follow-up; T: tuberous type of STOLF; F: fused-type PF STOLF; recovery rate.